Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa

Detalles Bibliográficos
Autores principales: Ntiri, Michel, Haskin, Alessandra, Lowenstein, Eve J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527620/
https://www.ncbi.nlm.nih.gov/pubmed/36199671
http://dx.doi.org/10.1016/j.jdcr.2022.08.048
_version_ 1784801114661584896
author Ntiri, Michel
Haskin, Alessandra
Lowenstein, Eve J.
author_facet Ntiri, Michel
Haskin, Alessandra
Lowenstein, Eve J.
author_sort Ntiri, Michel
collection PubMed
description
format Online
Article
Text
id pubmed-9527620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95276202022-10-04 Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa Ntiri, Michel Haskin, Alessandra Lowenstein, Eve J. JAAD Case Rep Case Report Elsevier 2022-09-05 /pmc/articles/PMC9527620/ /pubmed/36199671 http://dx.doi.org/10.1016/j.jdcr.2022.08.048 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ntiri, Michel
Haskin, Alessandra
Lowenstein, Eve J.
Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title_full Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title_fullStr Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title_full_unstemmed Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title_short Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
title_sort disseminated tuberculosis following negative quantiferon-tb gold tests during infliximab therapy: implications for screening of hidradenitis suppurativa
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527620/
https://www.ncbi.nlm.nih.gov/pubmed/36199671
http://dx.doi.org/10.1016/j.jdcr.2022.08.048
work_keys_str_mv AT ntirimichel disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa
AT haskinalessandra disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa
AT lowensteinevej disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa

Ejemplares similares